[1] Björnsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis[J].Hepatology, 2010,51(6):2040-2048.
[2] Yang F, Wang Q, Bian Z, et al. Autoimmune hepatitis: east meets west[J].Gastroenterol Hepatol, 2015,30(8):1230-1236.
[3] Mack C L, Adams D, Assis D N, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 Practice Guidance and Guidelines from the American Association for the Study of Liver Diseases[J].Hepatology, 2020,72(2):671-722.
[4] Li L, Jiang W, Wang J. Clinical analysis of 275 cases of acute drug-induced liver disease[J].Front Med China,2007,1(1):58-61.
[5] Stine J G, Chalasani N. Chronic liver injury induced by drugs: a systematic review[J].Liver Int,2015,35(11):2343-2353.
[6] 李春敏,张静怡,唐颖悦,等.药物诱导的自身免疫性肝炎研究进展[J].中华肝脏病杂志,2016,24(11): 874-876.
[7] 黄春洋,刘燕敏,黄云丽,等.药物性肝损伤患者伴自身免疫现象的临床特点分析[J].临床肝胆病杂志,2015,31(08):1303-1306.
[8] Alvarez F, Berg P A, Bianchi F B, et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis[J].J Hepatol,1999,31(5):929-938.
[9] Martínez-Casas O Y, Díaz-Ramírez G S, Marín-Zuluaga J I, et al. Differential characteristics in drug-induced autoimmune hepatitis[J].JGH Open,2018,2(3):97-104.
[10] Licata A, Maida M, Cabibi D, et al. Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study[J].Dig Liver Dis,2014,46(12):1116-1120.
[11] Rockey D C. An update: portal hypertensive gastropathy and colopathy[J].Clin Liver Dis,2019,23(4):643-658. |
